Kiewitz Sebastian D, Kruppa Michael, Riechers Alexander, König Burkhard, Cabrele Chiara
Fakultät für Chemie und Pharmazie, Universität Regensburg, Universitätsstr. 31, 93053 Regensburg, Germany.
J Mol Recognit. 2008 Mar-Apr;21(2):79-88. doi: 10.1002/jmr.872.
Synthetic agents specifically interacting with a protein interface are important not only for the better understanding of protein dimer or complex formation but also for medical applications. Here we describe the recognition of the helix-loop-helix (HLH) dimerization domain of the Id proteins by an artificial luminescent receptor containing two binding sites for a Lewis acid and a Lewis base, respectively. The Id proteins are inhibitors of bHLH transcription factors and play key roles during development of cancer. We show that a receptor/Id-HLH-domain complex was formed cooperatively (K(0.5) approximately 2 microM under physiological conditions) and with moderate specificity, as compared to the related MyoD and Max HLH domains. Accordingly, a preferred receptor binding motif, CYSR(K), was identified within the Id HLH domains. These results are promising and may be exploited to design highly selective synthetic receptors for the Id HLH domain.
特异性与蛋白质界面相互作用的合成试剂不仅对于更好地理解蛋白质二聚体或复合物的形成很重要,而且在医学应用中也很重要。在此,我们描述了一种人工发光受体对Id蛋白的螺旋-环-螺旋(HLH)二聚化结构域的识别,该受体分别含有两个用于路易斯酸和路易斯碱的结合位点。Id蛋白是bHLH转录因子的抑制剂,在癌症发展过程中起关键作用。我们表明,受体/Id-HLH结构域复合物协同形成(在生理条件下K(0.5)约为2 microM),与相关的MyoD和Max HLH结构域相比,具有中等特异性。因此,在Id HLH结构域内鉴定出了一个优选的受体结合基序CYSR(K)。这些结果很有前景,可用于设计针对Id HLH结构域的高选择性合成受体。